Related content

Clinical Trials of Prophylactic Implantable Defibrillator Therapy in Patients with Nonischemic Cardiomyopathy: What have We Learned and What can We Expect from Future Trials?

By Grimm W.  

Cardiac Electrophysiology Review, Vol. 7, Iss. 4, 2003-12 ,pp. : 463-467

Springer Publishing Company

Access to resources Recommend Favorite

Selection of patients for prophylactic treatment with implantable cardioverter-defibrillator

By Huikuri Heikki V.  

Scandinavian Cardiovascular Journal, Vol. 47, Iss. 5, 2013-10 ,pp. : 254-255

Informa Healthcare

Access to resources Recommend Favorite

Implantable Cardioverter Defibrillator Therapy in Patients with Ischemic or Non-Ischemic Cardiomyopathy and Nonsustained Ventricular Tachycardia

By Evonich Rudolph F.   Maheshwari Alok   Gardiner Joseph C.   Khasnis Atul   Kantipudi Sricharan   Ip John H.   Grimes Denise   Hayter Gregory   Thakur Ranjan K.  

Journal of Interventional Cardiac Electrophysiology, Vol. 11, Iss. 1, 2004-08 ,pp. : 59-65

Springer Publishing Company

Access to resources Recommend Favorite

Subcutaneous Implantable Cardioverter Defibrillator in Patients With Hypertrophic Cardiomyopathy: An Initial Experience

By  

JOURNAL OF THE AMERICAN HEART ASSOCIATION, Vol. 5, Iss. 2, 2016-02 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Global longitudinal strain and left atrial volume index improve prediction of appropriate implantable cardioverter defibrillator therapy in hypertrophic cardiomyopathy patients

By Debonnaire Philippe   Thijssen Joep   Leong Darryl   Joyce Emer   Katsanos Spyridon   Hoogslag Georgette   Schalij Martin   Atsma Douwe   Bax Jeroen   Delgado Victoria   Marsan Nina  

The International Journal of Cardiovascular Imaging, Vol. 30, Iss. 3, 2014-03 ,pp. : 549-558

Springer Publishing Company

Access to resources Recommend Favorite